A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy
about
Targeting inflammation in diabetes: Newer therapeutic optionsPathophysiology of diabetic retinopathyNovel pharmacotherapies in diabetic retinopathyA review of therapies for diabetic macular oedema and rationale for combination therapyTherapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathyNovel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic RetinopathyAngiopoietin 2 induces astrocyte apoptosis via αvβ5-integrin signaling in diabetic retinopathyDifferential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice.Plastic roles of pericytes in the blood-retinal barrier.Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in miceBone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathyThe development of blood-retinal barrier during the interaction of astrocytes with vascular wall cells.Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis.Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral strokeTaurine prevents high glucose-induced angiopoietin-2/tie-2 system alterations and apoptosis in retinal microvascular pericytes.Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier.Role of the retinal vascular endothelial cell in ocular diseaseDiabetic Retinopathy: Battling the Global Epidemic.Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.We have contact: endothelial cell-smooth muscle cell interactions.Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Therapeutic targeting of the angiopoietin-TIE pathway.The inner blood-retinal barrier: Cellular basis and development.Diabetic retinopathy and inflammation: novel therapeutic targets.Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis.The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.Diabetic Retinopathy: Pathophysiology and Treatments.Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis
P2860
Q26852726-0F1F963E-E796-495D-9E73-292533608AFFQ26865897-447DED38-BA8C-4DDE-B589-7EC1E9ABB8BAQ27002622-E990AF6B-14CC-4917-A1B9-B8750AED9870Q27008325-51CE87FE-0B81-4CFC-A7E4-C2BAB19AA0A6Q27021701-82375528-BA27-4CBA-8E0D-1AFAF36F75B7Q28066675-9915DDA3-88E7-4CC8-A536-65F4E8947F14Q28393006-1075BB27-4400-4F2F-B5B0-E5ABC53471D4Q33586788-84569515-4640-480C-96FF-EC315AB5BA8AQ33607716-6A94875E-D70B-4DF7-B3B4-18321AD48D8DQ33716453-3DDEA9AF-2DF7-4E73-B1EA-FFF2FFCF19F1Q33757106-5B5E4F43-A55C-4476-BE0A-3798DC14F1F9Q34005734-4A268660-346E-4965-BB7D-7B0042BD6F71Q34096257-92DD7737-1977-46C4-B749-02E5A66A4FF8Q34656695-F0E5590A-D82A-47D8-89EB-5BB010FDBCF8Q34987817-588D307D-27E3-4AC3-B670-45BC17BCAEDFQ35212928-A91C88B7-C221-4551-8DC6-F13B1272B40AQ35346991-20D2B68C-C3F1-4FDC-BA15-27C430CFB1BEQ35575592-59A5B17E-E3E4-42F8-ABCD-0F71C3DABFA1Q36919959-F79335C3-0F94-4140-A324-8ED229A5603FQ37494858-3DCDC25C-94E2-41A8-AD7C-0A98D0681BCFQ37629986-11D31BDA-E6EA-4DA1-858C-7079DF04EE98Q38225366-4F359EB0-61A8-4FF7-83F6-87C35DE296F5Q38877104-3D6A5296-F193-4227-A941-4E05D8DD63B6Q39103248-164B191E-3C61-446A-BFC8-46DDB14775E5Q39321127-B90CBF49-6795-4B53-9C9C-9D5DE6EEA8B6Q39376508-0FDA27F4-E7D4-402B-B288-2644225A827DQ41012046-EB0A0FCB-E1BE-4C22-9DCA-83C2EFF7470CQ47368100-1BB28BE9-71E0-4A33-85B7-D5468196709BQ48308877-2A2BC3D0-5858-49D7-96D3-76C9E3B10E57Q53111788-C2DAB4DA-4E44-4561-A7D0-E3AF157A162DQ55285122-FAC463DF-D8BF-407C-9963-DFF1390FD019Q55711452-A1AF902B-4DB6-4424-8BA6-6D9544BC1E9DQ58762933-65042D06-1EA3-48CB-8117-B626C4DC88FC
P2860
A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A potential role for angiopoie ...... arrier in diabetic retinopathy
@ast
A potential role for angiopoie ...... arrier in diabetic retinopathy
@en
type
label
A potential role for angiopoie ...... arrier in diabetic retinopathy
@ast
A potential role for angiopoie ...... arrier in diabetic retinopathy
@en
prefLabel
A potential role for angiopoie ...... arrier in diabetic retinopathy
@ast
A potential role for angiopoie ...... arrier in diabetic retinopathy
@en
P2093
P2860
P356
P1476
A potential role for angiopoie ...... arrier in diabetic retinopathy
@en
P2093
Joann Maestas
Paul G McGuire
Ramprasad Srinivasan
P2860
P304
P356
10.1167/IOVS.10-6386
P407
P50
P577
2011-06-01T00:00:00Z